Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

Stopped early · Not applicable

Conditions studied: Hearing Loss, Partial Deafness, Hearing Disorders, Ear Diseases, Otorhinolaryngologic Diseases

In brief

The purpose of this feasibility study is to evaluate whether low-frequency acoustic hearing sensitivity can be preserved in newly implanted adults with partial deafness (considerable low frequency acoustic hearing profiles with severe-to-profound high frequency sensorineural hearing loss) using the HiResolution™ 90K™ Advantage cochlear implant with the HiFocus™ Mid-Scala electrode to support the development of electro-acoustic stimulation technology (EAS).

Key facts

Study ID: NCT02189798
Run by: Advanced Bionics
People needed: 67
Starts: 2014-10-21
Expected to finish: 2022-03-29
Last updated by the study team: 2025-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Georgetown University School of Medicine — Washington D.C., District of Columbia, United States
Tampa Bay Hearing and Balance Center — Tampa, Florida, United States
University of Kentucky Medical Center — Lexington, Kentucky, United States
Mayo Clinic Rochester — Rochester, Minnesota, United States
University of Missouri — Columbia, Missouri, United States
Washington University — St Louis, Missouri, United States
Midwest Ear Institute/St. Luke's Health System — St Louis, Missouri, United States
New York University Langone Medical Center — New York, New York, United States
Oklahoma Ear Institute — Oklahoma City, Oklahoma, United States
Vanderbilt Bill Wilkerson Center — Nashville, Tennessee, United States
Austin Ear, Nose & Throat Clinic — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.